Search

Your search keyword '"Chloe M Reuter"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Chloe M Reuter" Remove constraint Author: "Chloe M Reuter"
49 results on '"Chloe M Reuter"'

Search Results

1. Researcher views on returning results from multi-omics data to research participants: insights from The Molecular Transducers of Physical Activity Consortium (MoTrPAC) Study

2. Patient experiences with clinical confirmatory genetic testing after using direct-to-consumer raw DNA and third-party genetic interpretation services

4. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

5. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

6. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

7. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

8. One is the loneliest number: genotypic matchmaking using the electronic health record

9. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

10. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder

11. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

12. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

13. Variant location is a novel risk factor for individuals with arrhythmogenic cardiomyopathy due to a desmoplakin (DSP) truncating variant

14. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

15. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

16. Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts

17. A toolkit for genetics providers in follow-up of patients with non-diagnostic exome sequencing

18. 'Doctors can read about it, they can know about it, but they’ve never lived with it': How parents use social media throughout the diagnostic odyssey

19. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

20. Arrhythmogenic Cardiomyopathy: Mechanisms, Genetics, and Their Clinical Implications

21. Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants

22. The genetic architecture of Plakophilin 2 cardiomyopathy

23. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

24. Abstract 15382: Variant Subtype and Regionality Aid Assessment of Pathogenicity in Plakophillin-2 ( PKP2 )

25. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

26. Genome Sequencing in Hypertrophic Cardiomyopathy

27. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

28. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

29. Correction to: The genetic architecture of Plakophilin 2 cardiomyopathy

30. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

31. Direct-to-consumer raw genetic data and third-party interpretation services: more burden than bargain?

32. Broad Genetic Testing in a Clinical Setting Uncovers a High Prevalence of Titin Loss-of-Function Variants in Very Early Onset Atrial Fibrillation

33. Pathological Overlap of Arrhythmogenic Right Ventricular Cardiomyopathy and Cardiac Sarcoidosis

34. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

35. De novo EIF2AK1 and EIF2AK2 variants are associated with developmental delay, leukoencephalopathy, and neurologic decompensation

36. Is Genetic Testing for Heart Disease Right for Me?

37. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

38. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing

39. Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy

40. Developing a genomics rotation: Practical training around variant interpretation for genetic counseling students

41. Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease

42. IRF2BPL Is Associated with Neurological Phenotypes

43. Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient

44. A Comprehensive Iterative Approach is Highly Effective in Diagnosing Individuals who are Exome Negative

45. Clinical Characteristics of the GLA N215S Variant and Implications for the Diagnosis and Management of Nonclassic Fabry Disease

46. A New Approach to Rare Diseases of Children: The Undiagnosed Diseases Network

47. Clinical Cardiovascular Genetic Counselors Take a Leading Role in Team-based Variant Classification

48. Truncating Variants in the Desmoplakin Gene Cause a Distinct Arrhythmogenic Cardiomyopathy

49. Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes

Catalog

Books, media, physical & digital resources